A 58-year-old male presents with a 4-week history of worsening morning headaches, personality changes, and a new-onset generalized seizure. Contrast-enhanced brain MRI reveals a 5-cm heterogeneous, thick ring-enhancing mass centered in the right frontotemporal region with central necrosis, perilesional vasogenic edema, and mass effect. Histopathological examination demonstrates a high-grade astrocytic neoplasm with microvascular proliferation and pseudopalisading necrosis. Molecular testing confirms IDH-wildtype status, EGFR amplification, and TERT promoter mutation. What is the definitive WHO 2021 diagnosis?
- AGlioblastoma, IDH-wildtype (CNS WHO Grade 4)
- BAstrocytoma, IDH-mutant (CNS WHO Grade 4)
- COligodendroglioma, IDH-mutant and 1p/19q-codeleted (CNS WHO Grade 3)
- DPleomorphic xanthoastrocytoma (CNS WHO Grade 2)